The expression of FADD in cancer cells is relatively low [13,15,54,55], and some studies have contributed that at low levels, FADD may contribute to NF-κB activation [64,65], while, seemingly in contrast to these studies, we and others reported that induced expression of FADD regulates NF-κB activation [18,30]. The gene discussed is NFKB1; the disease is cancer.